Evidence map›Paper›PMID 41180838›Full record

ReviewFrontiers in bioengineering and biotechnology2025

Photobiomodulation in fibroblasts: from light to healing through molecular pathways, omics and artificial intelligence.

Sarassunta Ucci, Eugenio Caradonna, Anna Aliberti, Andrea Cusano

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Light therapy in medicine: where do we stand?Annals of translational medicine · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarassunta UcciOptoelectronics Group, Department of Engineering, University of Sannio, Benevento, Italy.
Eugenio CaradonnaCentro Regionale Information Communication Technology, CeRICT scrl, Benevento, Italy.
Anna Aliberti *Optoelectronics Group, Department of Engineering, University of Sannio, Benevento, Italy.
Andrea Cusano *Optoelectronics Group, Department of Engineering, University of Sannio, Benevento, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photobiomodulation (PBM), a non-invasive therapy that uses non-ionizing light in the visible to near-infrared spectrum, has proven to be a promising strategy for promoting tissue repair and regeneration. PBM has its roots in heliotherapy and low level light therapies and works by activating specific molecular pathways in the target cells. Among these, fibroblasts play a central role in mediating wound healing responses. This article provides a comprehensive overview of the mechanisms of action of PBM, focusing on the effects on fibroblast biology, including modulation of proliferation, migration and extracellular matrix remodeling. Recent advances in omics technologies and artificial intelligence (AI) provide new tools to unravel the complexity of PBM-induced signaling and optimize therapeutic protocols. By integrating data-rich approaches and systems-level analysis, this work highlights the potential of PBM as a precision-guided regenerative modality and underscores the need for further translational studies to support its clinical application.

Indexed as

artificial intelligencefibroblastsmolecular signalingomicsphotobiomodulationregenerative medicinewound healing

Identifiers

PMID41180838
PMCPMC12571845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.